Unlock instant, AI-driven research and patent intelligence for your innovation.

BDNF gene-PEI derivative nano-particle composition, preparation method and application thereof

A nanoparticle and derivative technology, applied in gene therapy, drug combination, pharmaceutical formulation, etc., to achieve the effects of high transfection efficiency, uniform particle size distribution, and strong DNA binding ability

Inactive Publication Date: 2015-02-04
XIN HUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] At present, there is no report on the use of nanoparticle complexes composed of BDNF gene and PEI derivatives formed by copolymerization of low molecular weight PEI and phthalaldehyde, pyridinedicarbaldehyde, pyridazinedicarbaldehyde or imidazoledicarbaldehyde to treat Parkinson's disease.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • BDNF gene-PEI derivative nano-particle composition, preparation method and application thereof
  • BDNF gene-PEI derivative nano-particle composition, preparation method and application thereof
  • BDNF gene-PEI derivative nano-particle composition, preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Example 1 Preparation of BDNF gene-PEI derivative nanoparticle complex

[0046] Weigh a certain amount of PEI derivatives (PEI and imidazole dicarbaldehyde to form a copolymer, the weight average molecular weight of PEI is 800Da, X is 2,5-imidazole dicarbaldehyde) and dissolve it in water to make the concentration 2.0 mg / ml, pass through 0.45 μm water After membrane filtration, it is ready for use; draw a certain amount of BDNF gene solution and dilute it with water to form a 20 μg / ml BDNF gene stock solution. When preparing the complex of PEI derivatives and BDNF gene nanoparticles, according to the set mass ratio of a series of PEI derivatives and BDNF genes, the solution of PEI derivatives is diluted to the corresponding concentration, and then quickly added to the same volume and fixed concentration of BDNF In the gene solution, the final concentration of the BDNF gene was 20 μg / ml. Finally, the solution was uniformly mixed at 1000 rpm, and incubated at room temper...

Embodiment 2

[0047] Example 2 Agarose gel electrophoresis of BDNF gene-PEI derivative nanoparticle complex

[0048] Weigh 1.0 g of agarose, add 100 ml of 1×TAE buffer, heat and dissolve in a microwave oven, wait until the temperature drops to 65°C, add ethidium bromide (EB) to prepare a 1.0% agarose solution (containing 0.5 μg / ml ethidium bromide), pour it into the gel-making tank, insert the sample comb, and let it stand at room temperature for 0.5-1 hour until the gel solidifies. Then, pull out the sample comb, add TAE buffer to the electrophoresis tank to cover the gel, and wait for the sample to be loaded. Next, referring to the preparation method of the nanoparticle composite solution in Example 1, prepare nanoparticle composite solutions with different mass ratios, the mass ratios of PEI derivatives and BDNF genes in the nanoparticle composite solution are 0, 1, 2, 3, 5, 7, 10, 15, 20, 30, 50, 70, 80, 100. Marker chooses DS TM 5000 (100 – 5000 bp), load 2 μl; 6× loading buffer ...

Embodiment 3

[0049] Example 3 Transmission electron microscope observation of BDNF gene-PEI derivative nanoparticle complex

[0050] According to the preparation method of the nanoparticle complex solution in Example 1, a nanoparticle complex solution with a mass ratio of PEI derivative to BDNF gene of 20 was prepared, and the sample volume was 100 μl. First, 10 μl of the nanoparticle complex solution was slowly dropped on a 400-mesh copper grid, and dried naturally at room temperature. Finally, a transmission electron microscope was used to observe the shape of the sample, and the transmission electron microscope picture was recorded. Transmission electron microscopy shows that: PEI derivatives are added to the BDNF gene molecule, complexed by electrostatic force to form a complex, showing a spherical nano-particle, and its shape is regular and uniform. It is obvious that the BDNF gene molecule is wrapped in the polymer Inside, the nanoparticles have a particle size of 200 - 300 nm.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
particle diameteraaaaaaaaaa
Login to View More

Abstract

The invention relates to a BNDF gene-PEI derivative nano-particle composition, a preparation method and an application thereof. The nano-particle composition includes a BDNF gene substance and a PEI derivative, wherein a mass ratio of the PEI derivative to the BDNF gene substance is 20-80. The PEI is low-molecular-weight polyethyleneimine with a weight-average molecular weight is not more than 2000Da. X is phthalic aldehyde, dicarboxaldehyde, pyridazinedicarboxaldehyde or imidazoledicarboxaldehyde. The nano-particle composition is less in toxin, is high in transfection efficiency, can achieve both stability before arriving a target cell and a biologically-responsibility after entering the target cell during an in-vivo circulation process. Polycation itself can be metabolized toxic-free in-vivo so that the nano-particle composition can be used for treating Parkinson's disease and complications thereof through intracranially local injection.

Description

technical field [0001] The invention relates to the technical field of non-viral gene vectors, in particular to a BDNF gene-PEI derivative nanoparticle complex and a preparation method and application thereof. Background technique [0002] During the development of gene therapy, the study of gene delivery system, that is, gene carrier, has always been the focus of attention. Whether the gene carrier can safely and effectively carry genes to designated locations is the key to whether gene therapy can be applied clinically. Gene vectors can be divided into two categories: viral vectors and non-viral vectors. Although the viral vector is still the most used at present, its transfection efficiency can reach more than 90%, but the viral vector has its own insurmountable limitations, such as the ability to induce host immune response and potential carcinogenicity, the preparation is complicated, and it can The limited size of loaded exogenous DNA greatly limits its application. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K48/00A61K9/14A61K47/30A61P25/16A61P25/14
Inventor 袁伟恩刘振国车俊怡原明璐
Owner XIN HUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE